Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for DABIGATRAN ETEXILATE

Ingredient

DABIGATRAN ETEXILATE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-DABIGATRAN	150MG	CAPSULE	Resolved	2020-08-19	2021-01-26	122473
APO-DABIGATRAN	110MG	CAPSULE	Resolved	2024-06-14	2024-09-20	230561
APO-DABIGATRAN	110MG	CAPSULE	Actual shortage	2024-11-15	2024-11-15	243170
APO-DABIGATRAN	110MG	CAPSULE	Resolved	2024-12-05	2025-01-24	244888
APO-DABIGATRAN	110MG	CAPSULE	Resolved	2025-04-10	2025-05-23	254858
APO-DABIGATRAN	150MG	CAPSULE	Resolved	2020-04-13	2021-01-26	111898
APO-DABIGATRAN	150MG	CAPSULE	Resolved	2021-09-03	2023-09-15	145144
APO-DABIGATRAN	150MG	CAPSULE	Resolved	2023-04-14	2023-06-08	189659
APO-DABIGATRAN	150MG	CAPSULE	Resolved	2023-02-23	2023-03-23	185492
APO-DABIGATRAN	110MG	CAPSULE	Resolved	2024-02-09	2024-02-23	219152

1
2
3
Next

Showing 1 to 10 of 26

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
PRADAXA	110MG	CAPSULE	Discontinued	2017-12-21	2017-12-21	34114
PRADAXA	150MG	CAPSULE	Discontinued	2017-10-19	2017-10-19	26385
PRADAXA	75MG	CAPSULE	Discontinued	2025-04-17	2025-10-25	255171

1

Showing 1 to 3 of 3